Reasons Behind a Fund's Decision to Liquidate Its Holdings in a Healthcare REIT That Has Gained 77% in the Last Year
Global IMC's Exit from AHR: California-based Global IMC sold its entire stake in American Healthcare REIT (AHR), totaling 222,038 shares and valued at approximately $8.16 million, which previously represented 2.1% of its assets under management (AUM).
Performance of AHR: Despite the sale, AHR shares have performed well, increasing by 77% over the past year, significantly outperforming the S&P 500, which rose by 16.5% in the same period.
Strong Financials for AHR: American Healthcare REIT reported a GAAP net income of $55.9 million in the third quarter, with same-store net operating income (NOI) growing by 16.4% year-over-year, prompting management to raise full-year guidance.
Investment Strategy Insight: The sale reflects Global IMC's disciplined investment strategy, where smaller positions are often liquidated after strong stock performance, even if the underlying business fundamentals remain solid.
Trade with 70% Backtested Accuracy
Analyst Views on AHR
About AHR
About the author

- Executive Leave: Danny Prosky, CEO and President of American Healthcare REIT, Inc., has taken a medical leave of absence effective February 3, 2026, which may impact the continuity and stability of high-level decision-making within the company.
- Interim Appointment: The Board has appointed Chairman Jeffrey T. Hanson as Interim CEO to ensure operational continuity during Prosky's absence, reflecting the company's trust and support in its executive team.
- Leadership Stability: Hanson stated he will work closely with the senior leadership team to continue executing the company's strategic priorities, demonstrating the company's adaptability in the face of executive changes.
- Company Overview: American Healthcare REIT focuses on acquiring and operating a diversified portfolio of clinical healthcare real estate, primarily including senior housing communities, skilled nursing facilities, and outpatient medical buildings, indicating its market positioning in the healthcare real estate sector.
- Executive Leave: American Healthcare REIT's CEO and President Danny Prosky has taken a medical leave effective February 3, 2026, due to a recent medical event, highlighting potential vulnerabilities in executive health that may impact investor confidence.
- Interim Appointment: Chairman Jeffrey T. Hanson has been appointed as Interim CEO to ensure operational continuity during Prosky's absence, demonstrating the company's crisis management capabilities and commitment to stability.
- Leadership Stability: Hanson emphasized his collaboration with the senior leadership team to continue executing the company's strategic priorities, reflecting trust in the management team and a commitment to business continuity during this transition.
- Company Overview: American Healthcare REIT focuses on acquiring and operating a diversified portfolio of clinical healthcare real estate, primarily including senior housing, skilled nursing facilities, and outpatient medical buildings, showcasing its strategic positioning in the healthcare real estate sector.
- Rating Changes Overview: Top Wall Street analysts have adjusted their ratings on several stocks, including upgrades, downgrades, and initiations, reflecting varying market perspectives on these companies.
- Market Impact: The changes in analysts' ratings could influence investor decisions, particularly for those considering buying SBET stock, highlighting the importance of understanding these ratings.
- Information Source: A complete view of all analyst rating changes can be found on Benzinga's analyst ratings page, offering a comprehensive market perspective.
- Investment Advice: While Benzinga provides market data, it does not offer specific investment advice, leaving investors to assess risks and rewards independently.
- MidCap Addition: TTM Technologies (TTMI) will be added to the S&P MidCap 400 on January 30, 2026, highlighting its recognition in the information technology sector, which is expected to enhance its market liquidity and investor interest.
- MidCap Deletion: Civitas Resources (CIVI) will be removed from the S&P MidCap 400 on the same date, which may impact its stock performance and market confidence, reflecting its relative weakness in the energy sector.
- SmallCap Addition: Amneal Pharmaceuticals (AMRX) will join the S&P SmallCap 600 on January 30, 2026, strengthening its market position in the healthcare industry and likely attracting more investor attention.
- SmallCap Deletion: TTM Technologies (TTMI) will also be removed from the S&P SmallCap 600 on the same date, indicating its poor performance in the small-cap market, which may lead investors to reassess its investment value.
- Constituent Changes: TTM Technologies will replace Civitas Resources in the S&P MidCap 400 on January 30, indicating ongoing market interest in tech stocks, which may enhance TTMI's market liquidity.
- Acquisition Activity: SM Energy is acquiring Civitas Resources, expected to close soon, allowing SM Energy to retain its position in the SmallCap 600, thereby strengthening its competitive edge in the market.
- New Additions: Dutch Bros and Advanced Energy Industries will join the S&P MidCap 400 on February 2, highlighting growth potential in the consumer and tech sectors, which may attract more investor attention.
- Liquidation Impact: Elme Communities is undergoing liquidation, leading to its removal from the SmallCap 600, reflecting the market's emphasis on financial health, which could affect investor confidence in related stocks.

- S&P Indices Update: Several companies, including TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Health Care, are set to join the S&P MidCap 400 index.
- Market Impact: The inclusion of these companies in the S&P MidCap 400 is expected to influence market dynamics and investor interest in these sectors.









